Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

KRYSTAL BIOTECH, INC.

(KRYS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 3009591 1821 346--
Entreprise Value (EV)1 3007749189991 0651 147
P/E ratio -21,4x-46,2x-35,1x-16,3x-18,8x-150x
Yield ------
Capitalization / Revenue ----4,04x12,8x
EV / Revenue ----3,19x10,9x
EV / EBITDA -25,5x-36,3x-29,5x-17,9x-14,8x-12,3x
Price to Book ------
Nbr of stocks (in thousands) 14 42917 30819 70822 205--
Reference price (USD) 20,855,460,060,660,660,6
Announcement Date 03/12/201903/10/202003/01/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 ----333105
EBITDA1 -11,8-21,3-31,1-55,7-71,9-93,3
Operating profit (EBIT)1 -11,9-22,1-33,0-81,1-79,6-27,3
Operating Margin -----23,9%-26,1%
Pre-Tax Profit (EBT)1 -10,9-19,1-32,2-86,9-81,3-15,8
Net income1 -10,9-19,1-32,2-86,9-80,5-18,3
Net margin -----24,1%-17,5%
EPS2 -0,97-1,20-1,71-3,72-3,22-0,40
Dividend per Share2 ------
Announcement Date 03/12/201903/10/202003/01/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q3 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4
Net sales1 ------
EBITDA1 -9,20-9,93-13,8-14,5-14,6-14,9
Operating profit (EBIT)1 -9,68-10,4-14,4-16,7-18,9-19,8
Operating Margin ------
Pre-Tax Profit (EBT)1 -9,61-10,4-15,8-18,2-20,9-22,1
Net income1 -9,61-10,4-15,8-18,2-20,9-22,1
Net margin ------
EPS2 -0,49-0,53-0,74-0,80-0,87-0,90
Dividend per Share ------
Announcement Date 11/09/202003/01/202105/10/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 -184264346281199
Leverage (Debt / EBITDA) -8,64x8,49x6,22x3,91x2,13x
Free Cash Flow1 ---40,9-103-108-61,8
ROE (Net Profit / Equities) ------
Shareholders' equity1 ------
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share ------
Cash Flow per Share ------
Capex1 --14,826,523,722,8
Capex / Sales ----7,11%21,8%
Announcement Date 03/12/201903/10/202003/01/2021---
1 USD in Million
Key data
Capitalization (USD) 1 345 600 396
Number of employees 75
Free-Float 75,4%
Free-Float capitalization (USD) 1 014 655 009
Avg. Exchange 20 sessions (USD) 10 192 702
Average Daily Capital Traded 0,76%
EPS & Dividend